Inexpensive drug fights cancer but no funds for tests
According to an article written by Denise Heckbert of the Columbia News Service, a new treatment for cancer could cost as little as $2 a dose and be as easy to administer as taking a pill or getting a shot. But scientists are struggling to find financing for further research because the drug can not be patented. The drug, dichloroacetate, or DCA, was discovered last month, by scientists working at the University of Alberta while using the drug to treat rare metabolic diseases. It seemed to halt the spread of cancer. Unlike chemotherapy and other current cancer treatments that kill both sick and healthy cells, causing side effects like nausea and hair loss, DCA seems to leave healthy cells unharmed. The scientists have set up a site for donations to support testing at Xact.ualberta.ca/giveonline. A DCA site has also been set up to explain the drug and possible actions that you might take. However, before donating, we urge you to thoroughly investigate the situation.
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.
Comments
No comments yet.
Leave a comment